The WACC of Harvard Bioscience Inc (HBIO) is 9.1%.
Range | Selected | |
Cost of equity | 8.90% - 12.00% | 10.45% |
Tax rate | 11.50% - 22.20% | 16.85% |
Cost of debt | 6.30% - 7.00% | 6.65% |
WACC | 8.0% - 10.2% | 9.1% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 1.11 | 1.28 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 8.90% | 12.00% |
Tax rate | 11.50% | 22.20% |
Debt/Equity ratio | 0.39 | 0.39 |
Cost of debt | 6.30% | 7.00% |
After-tax WACC | 8.0% | 10.2% |
Selected WACC | 9.1% | |